Name: Advancing Conversations: Aubrey de Grey - Advocate for an Indefinite Human Lifespan (en Inglés)
Price: 54.42 PEN
Availability: InStock
Author: Lain, Douglas ; de Grey, Aubrey
ISBN: 9781785353963

portada Advancing Conversations: Aubrey de Grey - Advocate for an Indefinite Human Lifespan (en Inglés)

Formato

Libro Físico

Autor

Aubrey de Grey

Douglas Lain

Editorial

Zero Books

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

21.1 x 13.5 x 0.8 cm

Peso

0.10 kg.

ISBN13

9781785353963

Categorías

Vejez y envejecimiento

Advancing Conversations: Aubrey de Grey - Advocate for an Indefinite Human Lifespan (en Inglés)

Aubrey de Grey (Autor) · Douglas Lain (Autor) · Zero Books · Tapa Blanda

Libro Nuevo

S/ 54,42

S/ 108,85

Ahorras: S/ 54,42

50% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 15 de Julio y el Lunes 29 de Julio.

Lo recibirás en cualquier lugar de Perú entre 2 y 5 días hábiles luego del envío.

Reseña del libro "Advancing Conversations: Aubrey de Grey - Advocate for an Indefinite Human Lifespan (en Inglés)"

Advancing Conversations is a line of interview books documenting conversations with artists, authors, philosophers, economists, scientists, and activists whose works are aimed at the future and at progress. The biogerontologist Aubrey de Grey, as the world's pre-eminent longevity advocate, is nothing if not future oriented. De Grey is the founder of the SENS Research Foundation, an organization developing medical interventions to repair the damage the body does to itself over time. Stated more directly, Aubrey de Grey and his organization aim to defeat aging. In 2005 a panel of scientists and doctors from MIT, Brigham and Women's Hospital in Boston, Microsoft, and the Venter Institute participated in a contest to judge whether de Grey's "Strategies for Engineered Negligible Senescence" were worthy of debate and verification or whether these ideas were wrong on their face. The panel found that de Grey's proposals for intervening in the aging process, while speculative, often "ran parallel to existing research" and were not "demonstrably wrong."